Beam Therapeutics Inc. · NASDAQ:BEAM

Beam Therapeutics Inc. insider trades

Beam Therapeutics Inc.'s insiders made 0 buys and 18 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

InsiderTradeSharesPriceValueDate
Evans John M.
Director, Officer: CEO
Sale25,000USD 23.98US$600KOct 16, 2026
Evans John M.
Director, Officer: CEO
Sale25,000USD 23.57US$589KOct 15, 2026
Cavanagh Bethany J
Officer: SVP, Finance and Treasurer
Sale187USD 24.41US$4,565Oct 1, 2026
Simon Amy
Officer: Chief Medical Officer
Sale16,667USD 25.74US$429KJul 27, 2026
Simon Amy
Officer: Chief Medical Officer
Sale373USD 34.73US$12,954Jun 30, 2026
Evans John M.
Director, Officer: CEO
Sale23,100USD 34.26US$791KJun 30, 2026
Evans John M.
Director, Officer: CEO
Sale1,900USD 34.84US$66,196Jun 30, 2026
Evans John M.
Director, Officer: CEO
Sale13,421USD 35.13US$471KJun 29, 2026
Evans John M.
Director, Officer: CEO
Sale11,579USD 35.91US$416KJun 29, 2026
FMR LLC
10% owner, Other: See Remark 1
Sale251,488USD 35.26US$8.87MJun 26, 2026
FMR LLC
10% owner, Other: See Remark 1
Sale33,372USD 35.12US$1.17MJun 25, 2026
Ciaramella Giuseppe
Officer: President
Sale11,810USD 24.58US$290KApr 1, 2026
Bellon Christine
Officer: Chief Legal Officer
Sale5,956USD 24.58US$146KApr 1, 2026
Cavanagh Bethany J
Officer: SVP, Finance and Treasurer
Sale3,242USD 24.58US$79,688Apr 1, 2026
Simon Amy
Officer: Chief Medical Officer
Sale6,700USD 24.58US$165KApr 1, 2026
Evans John M.
Director, Officer: CEO
Sale30,078USD 24.58US$739KApr 1, 2026
Evans John M.
Director, Officer: CEO
Sale25,000USD 22.76US$569KMar 31, 2026
Evans John M.
Director, Officer: CEO
Sale25,000USD 22.37US$559KMar 30, 2026

Beam Therapeutics Inc. shareholders